SEC Filing Summary

Brent Pfeiffenberger, President and CEO of Century Therapeutics, Inc., reported a disposition of 463 shares of Common Stock on June 5, 2026. The transaction, coded as "F" and "D", occurred at a price of $2.13 per share. Following this transaction, Mr. Pfeiffenberger owns 3,679,323 shares of common stock. The filing also references a footnote indicating that shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. This transaction is classified as a disposition of stock by an insider.